Runben Biotechnology Co., Ltd. (SHA:603193)
20.85
-0.20 (-0.95%)
Mar 26, 2026, 2:14 PM CST
-37.80% (1Y)
| Market Cap | 8.52B -26.1% |
| Revenue (ttm) | 1.52B +21.8% |
| Net Income | 305.33M -0.3% |
| EPS | 0.76 -0.1% |
| Shares Out | 404.59M |
| PE Ratio | 27.73 |
| Forward PE | 25.26 |
| Dividend | 0.46 (2.19%) |
| Ex-Dividend Date | n/a |
| Volume | 857,200 |
| Average Volume | 1,466,502 |
| Open | 21.05 |
| Previous Close | 21.05 |
| Day's Range | 20.85 - 21.27 |
| 52-Week Range | 20.28 - 44.00 |
| Beta | 0.02 |
| RSI | 32.41 |
| Earnings Date | Apr 23, 2026 |